Clinical Trials Browser

Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Endometrial Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Advanced Solid Tumors

Squamous Cell Carcinoma of Head and Neck

Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Pancreatic Adenocarcinoma

Colorectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Brain Neoplasms, Glioma

Colorectal Neoplasms

Colorectal Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Neoplasm Metastasis, Neoplasms

Neoplasm Metastasis, Neoplasms

Colonic Neoplasms

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Neoplasms

Colorectal Neoplasms

Recurrence Free Survival

Colorectal Neoplasms

Clinical Trials

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

AndroMETa-CRC

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

CodeBreaK 301

A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

VICTORIA

TRIFLUOX-DP

BOREALIS-1

AURORAS-1

The Sagittarius Trial

OSCAR

A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

IMPROVE-2

Liquid-DRER2

CRC01

DRUP